microRNA-25 drives immune checkpoint therapy resistance by repressing innate and humoral immunity via Syndecan-3

Journal:

Nature Communications

Published:

2026-05-20

DOI:

10.1038/s41467-026-73339-y

Affiliations:

3

Authors:

18

Go to article

Institutions	Authors	Share
University of California, San Diego (UC San Diego), United States of America (USA)	15.000000 15.000000	0.83
Sanford Burnham Prebys Medical Discovery Institute (SBP), United States of America (USA)	1.500000	0.08
Moores Cancer Center, United States of America (USA)	1.500000	0.08

Interested in Immunology?